NEW YORK (GenomeWeb News) – French biotech Genomic Vision today announced it and Quest Diagnostics have extended their strategic alliance agreement originally forged in 2011.

Under the terms of the extension, Quest will invest in the planned development of a laboratory-developed test for an undisclosed hereditary genetic disease. The two firms also will collaborate on automating the testing process and improving turnaround times for tests that use Genomic Vision's DNA combing technique.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.